Dr. Sennewald Medical Technology

What Dr. Sennewald Medical Technology does

Dr. Sennewald Medizintechnik GmbH is a privately held German medical technology company founded in 1985 by Dr. Gerhard Sennewald and headquartered in Munich. The company operates as a specialized clinical oncology distributor and proprietary software developer, distributing hyperthermia systems from Pyrexar Medical (BSD-500 superficial system, BSD-2000 deep regional system, BSD-2000 3D with phased-array control, and BSD-2000 3D/MR hybrid MRI-guided system) and, since 2024, holding exclusive German distribution rights for FLASH radiotherapy systems from S.I.T. Sordina IORT Technologies. Its primary customers are hospital radiation oncology and radiotherapy departments across Germany, Switzerland, Austria, the Netherlands, Norway, Italy, and Poland, including named university medical centers such as Charité Berlin, Klinikum Großhadern München, Universitätsklinikum Erlangen, Erasmus MC Rotterdam, and Kantonsspital Aarau.

The company develops and maintains two proprietary MDR-certified medical device software products: HyperPlan, a treatment planning platform with 3D visualization, dose-volume histogram analysis, and PACS integration for patient-specific hyperthermia protocols; and SigmaVision Advanced, an MR thermometry software (EU MDR Risk class IIb) for non-invasive 3D temperature monitoring during hybrid hyperthermia treatments, co-developed with Charité Universitätsmedizin Berlin. The product portfolio leverages regulatory moats including the only FDA-approved hyperthermia systems worldwide (BSD-2000 HDE for cervical cancer, BSD-500 cleared for palliative use) and EU MDR 2017/745 certifications.

The business model combines hardware distribution (capital equipment sales of BSD systems and FLASH radiotherapy units), software licensing (HyperPlan and SigmaVision Advanced), and professional services including installation, configuration, and after-sales support. Go-to-market is a direct enterprise field sales motion led by Sales Manager Frank Mittnacht, supplemented by active participation at ESHO, DEGRO, SASRO, ESTRO, ÖGRO and other radiation oncology and hyperthermia conferences, plus a multilingual digital presence and monthly newsletter. The company is family-influenced (Vice-President Marketing Monica Sennewald) and has not disclosed external institutional ownership or funding.

Name

Dr. Sennewald Medical Technology

Legal name

Dr. Sennewald Medizintechnik GmbH

Website

https://sennewald.de

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

11–50 employees

Short description

Dr. Sennewald Medizintechnik GmbH distributes Pyrexar Medical hyperthermia systems and S.I.T. Sordina FLASH radiotherapy systems, and develops MDR-certified HyperPlan and SigmaVision Advanced software, serving hospital radiation oncology departments across Europe.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

Keywords

• Hyperthermia systems
• Radiotherapy equipment
• Treatment planning software
• MR thermometry
• Oncology devices

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Hyperthermia System Distribution: Distribution of BSD-500, BSD-2000, BSD-2000 3D, and BSD-2000 3D/MR hyperthermia systems from Pyrexar Medical. These are capital equipment sales requiring direct sales engagement with hospitals and clinics.
2. FLASH Radiotherapy System Distribution: Exclusive German distribution of FLASH radiotherapy systems from S.I.T. - Sordina IORT Technologies since 2024.
3. HyperPlan Software Licensing: MDR-certified treatment planning software sold to clinical facilities for hyperthermia treatment planning and monitoring.
4. SigmaVision Advanced Software: MR thermometry software for hybrid hyperthermia systems, certified as medical device class IIb.
5. Service and Support: Comprehensive service including installation, configuration, and after-sales support for distributed medical equipment.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels9 records

Core offering

Dr. Sennewald Medical Technology distributes BSD (Pyrexar Medical) hyperthermia systems and FLASH radiotherapy systems from S.I.T. Sordina IORT Technologies for cancer treatment. The company also develops proprietary software including HyperPlan for treatment planning and Sigmavision Advanced for MR thermometry, serving hospitals, oncology clinics, and university medical centers in combined hyperthermia-radiotherapy treatments.

Product overview

Dr. Sennewald Medizintechnik distributes a portfolio of hyperthermia systems from Pyrexar Medical (BSD-500, BSD-2000, BSD-2000 3D, BSD-2000 3D/MR) for clinical oncology and develops proprietary software products (HyperPlan for treatment planning, Sigmavision Advanced for MR thermometry monitoring). Since 2024, the company has also become the exclusive German distributor of FLASH radiotherapy systems from S.I.T. - Sordina. The BSD series systems use phased-array RF technology for regional and superficial hyperthermia treatments, while the in-house software products provide treatment planning, simulation, and temperature monitoring capabilities that integrate with the hardware systems.

Differentiator

Problem solved

Functional benefit

Brands

• HyperPlan: MDR-certified medical planning software for patient-specific hyperthermia treatment planning
• Sigmavision Advanced
• FLASH by SIT

Products and services

• BSD-500

Quantifiable outcome

• Phase III study showed significant improvement in local progression-free survival (HR 0.65) for high-risk soft tissue sarcoma patients treated with chemotherapy plus regional hyperthermia vs chemotherapy alone
• +4 more outcomes

Named customers9 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• S.I.T. - Sordina IORT TechnologiescoreChannel Partner/ Reseller/ Distributor · 1 January 2024Exclusive German distributor of FLASH radiotherapy systems since 2024. The partnership extends the company's product portfolio beyond hyperthermia into innovative radiotherapy technology. Dr. Sennewald serves as the exclusive distribution partner for the German market.
• Pyrexar MedicalcoreChannel Partner/ Reseller/ DistributorLong-term partnership with the pioneer and world market leader in hyperthermia medical systems. Distribution of BSD-500, BSD-2000, BSD-2000 3D, and BSD-2000 3D/MR hyperthermia systems for clinical oncology. Pyrexar systems are the only FDA-approved hyperthermia systems worldwide.
• Charité – Universitätsmedizin BerlincoreStrategic or Co-development PartnerStrategic collaboration with leading university hospital for Hyperplan software development and clinical research. Professor Dr. Daniel Zips (Director of Radiation Oncology), Professor Dr. Pirus Ghadjar (Senior Physician, Hyperthermia), Dr. Jacek Nadobny, and Ph.D. Anna Chiara Giovannelli participate in software development and clinical validation. Interview with Prof. Dr. Ghadjar featured on company website regarding Hyperplan significance for clinical hyperthermia.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Pyrexar Medical: Utah-based manufacturer of the BSD-2000 family of hyperthermia systems that Sennewald distributes. Both companies are focused exclusively on clinical hyperthermia, making Pyrexar the closest product-level peer despite the partnership relationship.
• Celsius42 GmbH: German developer of hyperthermia systems for superficial and deep-seated tumors. Competes head-to-head with Sennewald's BSD portfolio in German and European university clinics.
• Oncotherm Group: Hungarian-German manufacturer of capacitive hyperthermia devices (e.g., EHY-2000) used as adjunctive oncology therapy. Directly competes with BSD systems in European clinical oncology accounts.
• MagForce AG: Berlin-listed medtech company commercializing NanoTherm, a nano-particle-based focal hyperthermia therapy for brain and prostate cancer. Operates in the same hyperthermia-as-oncology-adjunct category.
• S.I.T. - Sordina IORT Technologies: Italian manufacturer of intraoperative radiotherapy (IORT) and FLASH systems, including the LIAC and FLASH platforms that Sennewald exclusively distributes in Germany. Direct peer in FLASH radiotherapy and broader radiation oncology hardware.
• Andromedic: Spanish medical equipment group with a hyperthermia product line targeting European oncology clinics. Competes for the same European university hospital procurement budgets as Sennewald.

Broad incumbents

• Accuray Incorporated: U.S.-based manufacturer of CyberKnife and TomoTherapy radiation therapy systems. Competes for radiation oncology capital budgets and provides another benchmark for hypofractionated and novel dose-rate workflows.
• Varian Medical Systems (Siemens Healthineers): Global incumbent in linear accelerators, brachytherapy, and proton therapy. Sets the standard against which adjunct modalities like hyperthermia and FLASH must justify incremental hospital spend.
• IntraOp Medical Corporation: U.S. manufacturer of mobile electron-beam IORT systems (Mobetron). Operates in adjacent intraoperative/FLASH-adjacent radiation oncology hardware space relevant to Sennewald's FLASH distribution.
• Elekta AB: Swedish global leader in radiation therapy (linear accelerators, Gamma Knife, Unity MR-linac). Competes with Sennewald for hospital radiotherapy capital budgets and increasingly offers integrated image-guided workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/drsennewald
• YouTubeyoutube.com/channel/UCmkuCGKHnJ-YM4-kOBjFjVg
• Facebookfacebook.com/sennewald
• LinkedInlinkedin.com/company/dr.-sennewald-medizintechnik-gmbh

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dr. Sennewald Medical Technology